期刊文献+

肿瘤坏死因子和血管内皮生长因子在大肠癌中的表达及意义 被引量:2

Clinicopathological significance of TNFαand VEGF expression in colorectal cancer
暂未订购
导出
摘要 目的:探讨肿瘤坏死因子(Tumer necrosis factor,TNFα)、血管内皮生长因子(Vascular endothelial growth factor,VEGF)在大肠癌中的表达及其与肿瘤病理分级、Dukes分期的关系。方法:大肠癌组织50例,大肠腺瘤20例,正常组织20例,采用免疫组化二步法对标本切片进行染色。结果:TNFα、VEGF在癌组织中表达明显高于正常组织和腺瘤,三者之阃差异显著(P<0.05)。VEGF表达与病理分级、Dukes分期呈正相关性,而TNFα表达则相反(P<0.01)。TNFα与VEGF在癌组织中的表达呈负相关。(P<0.01)。结论:TNFα及VEGF的检测可作为大肠癌预后估计的客观指标。 Objective: To investigate the expression of TNFα and VEGF antigen in the eolorectal cancer and their relationship with pathological stage, dukes stage and prognosis of coloreetal cancer. Methods: Immunohistochemical staining two - step method are used to detect TNFα, VEGF antigen expression in normal mucous tissue(20 eases) ,in adenoma tissue(20cases) and in coloreetal cancer tissue(50 eases). Result: TNFα and VEGF antigen level were significantly different in the colorectal cancer tissue, in the adenoma tissue and in the normal mucous tissue(P 〈 0.01 ).The expression of TNFα and VEGF were significantly higher in the coloreetal cancer than that of adenoma tissue and normal mucoes tissue. TNFα and VEGF expression were closely correlated with the pathological stage, Dukes stage(P 〈0.05). It is negative correlation between TNFα and VEGF in the colorectal cancer tissue. Conclusion: TNFα and VEGF are both associated with the growth of the cnlorectal cancer. TNFα and VEGF are objective predictable indicator for prognosis of colorectal cancer.
出处 《现代生物医学进展》 CAS 2006年第9期36-38,共3页 Progress in Modern Biomedicine
关键词 大肠癌 TNFΑ VEGF 免疫组化 Colorectal cancer TNFα VEGF Immunohistochemistry
  • 相关文献

参考文献4

二级参考文献37

  • 1高朋根,苏蕴,高友春,刘习昌,王继信,张友会.津白Ⅱ小鼠自发乳癌(ⅥTA_2MA-891)高自发肺转移模型[J].中国医学科学院学报,1994,16(2):147-152. 被引量:12
  • 2Gille H, Kowalski J, Li B, et 8.1. Analysis of biological effects and signaling properties of Fit - 1 ( VEGFR - 1 ) and KDR( VEGFR - 2 )[J]. J Biol Chem ,2001,276:3222 - 3230.
  • 3Dumont DJ, Jussila L, Taipale J, et 81. Cardiovascular failure in mouse embryos deficient in VEGF Receptor-3 [J]. Science,1998,282:946 - 949.
  • 4Ferrajoli A ,Manshouri T,Estrov Z,et a]. High levels of vasodar endothelial growth factor receptor -2 cone]ate with shortened survival inchnmic lymphocytic leukemia[ J]. Clin Cancer Res ,2001,7:795 - 799.
  • 5Dankbar B,Padro T,Le R,et al. Vascular endothelial growth factor and interleukin - 6 in paracrine tumor - stromal cell interactions in multiple myeloma[J]. Blood,2000,95:2630 -2636.
  • 6Roeckl W,Hecht D,Sztajer H ,et al. Differet,tial binding characteristics and cellular inhibition by soluble forms of KDR and FLT - 1[J]. Exp Cell Res ,1998 ,241:161 -170.
  • 7Neufeld G, Cohen T. Vascular endothelial growth factor(VEGF) and its receptors[ J]. FASEB J,1999,13:9 -22.
  • 8Vincenti V, Cassano C, Rocchi M, et 81. Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3 [ J ].Circulation, 1996,93 : 1493 - 1495.
  • 9Grimmond S, Lagererantz J, Drinkwater C, et 81. Cloning and characterization of a novel human gene related to vascular endothelial growth factor[ J]. Genome Res, 1996,6 : 124 - 131.
  • 10Paavonen K, Horelli -Kuitunen N, Chilov D, et 81. Novel human vasculax endothelial growth factor genes VEGF - B and VEGF - C localize to chromosomes 11 q13 and 4 q34, respectively [ J]. Circulation, 1996,93:1079 - 1082.

共引文献34

同被引文献45

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部